V

VolitionRX Limited
D

VNRX

0.64240
USD
0.02
(3.61%)
مغلق
حجم التداول
229
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
61,649,746
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    V
    VKTX
    -0.155
    (-0.37%)
    42.160 USD
    V
    VNRX
    0.02240
    (3.61%)
    0.64240 USD
    V
    VRAY
    -0.07500
    (-2.12%)
    3.46000 USD
    V
    VRNA
    -0.190
    (-0.42%)
    45.190 USD
    V
    VTVT
    -1.010
    (-6.99%)
    13.430 USD
    V
    VYNE
    0.38000
    (14.79%)
    2.95000 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار
المقالات

العنوان: VolitionRX Limited

القطاع: Healthcare
الصناعة: Diagnostics & Research
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.